Lonidamine

氯尼达明

Report date: 2024/11/21 15:59:33
NME

Base Information

Drug NameLonidamine
Drug Alias NameDiclondazolic acidDoridaminaKN-228TH-070AF-1890
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHexokinase inhibitors
TargetsHexokinase
Therapy Area/IndicationsProstatic HyperplasiaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandItaly +[5
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesThreshold Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThreshold Pharmaceuticals
Active IndicationsNeoplasms
Inactive IndicationsProstatic Hyperplasia

Other Information

ATC CodeL01XX07
Related LinksWikipediaKEGG